This difference may be attributed to the intrinsic instability and rapid degradation of HIF-1α, suggesting the possibility that long-acting iron chelators may robustly induce HIF-1α in tumors, thereby exerting a tumor-suppressive effect. Here, HIF1A is linked to neoplasm.